A contemporary review of mechanical circulatory support

Journal of Heart and Lung Transplantation

Volumn 33, Issue 7, 2014, Pages 667-674

  Patel, Chetan B ^a   Cowger, Jennifer A ^b   Zuckermann, Andreas ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b St Vincent s Heart Center of Indiana   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

bridge to transplantation; cardiac transplantation; destination therapy; heart failure; mechanical circulatory support

Indexed keywords

HEART FAILURE; HEART TRANSPLANTATION; HIGH RISK POPULATION; HOSPITAL READMISSION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MYOCARDIAL DISEASE; OUTCOME ASSESSMENT; PHYSIOLOGY; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT; SHORT COURSE THERAPY; SURVIVAL; TREATMENT INDICATION; HEART ASSIST DEVICE; RISK FACTOR; TREATMENT OUTCOME; TRENDS;

HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84904255589     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.02.014     Document Type: Article

References (58)

1. J.K. Kirklin, D.C. Naftel, and R.L. Kormos et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients J Heart Lung Transplant 32 2013 141 156
2. J.J. Teuteberg, G.C. Stewart, and M. Jessup et al. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) JCHF 1 2013 369 378
3. L.H. Lund, L.B. Edwards, and A.Y. Kucheryavaya et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report - 2013; focus theme: age J Heart Lung Transplant 32 2013 951 964
4. M. Colvin-Adams, J.M. Smith, and B.M. Heubner et al. OPTN/SRTR 2011 Annual Data Report: heart Am J Transplant 13 Suppl 1 2013 119 148
5. N. Uriel, U.P. Jorde, and S. Woo Pak et al. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation J Heart Lung Transplant 32 2013 188 195
6. O. Wever-Pinzon, S.G. Drakos, and A.G. Kfoury et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation 127 2013 452 462
7. A.H. Healy, B.C. Baird, S.G. Drakos, J. Stehlik, and C.H. Selzman Impact of ventricular assist device complications on posttransplant survival: an analysis of the United Network of Organ Sharing database Ann Thorac Surg 95 2013 870 875
8. J.M. Gelow, H.K. Song, J.B. Weiss, J.O. Mudd, and C.S. Broberg Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices J Heart Lung Transplant 32 2013 1059 1064
9. N. Shankar, R. Daly, and J. Geske et al. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay Transplantation 96 2013 324 330
10. S.J. Park, C.A. Milano, and A.J. Tatooles et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy Circ Heart Fail 5 2012 241 248
11. K.D. Aaronson, M.S. Slaughter, and L.W. Miller et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
12. A.D.M. Grant, N.G. Smedira, R.C. Starling, and T.H. Marwick Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation J Am Coll Cardiol 60 2012 521 528
13. R.P. Vivo, A.M. Cordero-Reyes, and U. Qamar et al. Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device J Heart Lung Transplant 32 2013 792 799
14. J. Cowger, K. Sundareswaran, and J.G. Rogers et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score J Am Coll Cardiol 61 2013 313 321
15. J.J. Teuteberg, G.A. Ewald, and R.M. Adamson et al. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients J Am Coll Cardiol 60 2012 44 51
16. J.C. Matthews, F.D. Pagani, J.W. Haft, T.M. Koelling, D.C. Naftel, and K.D. Aaronson Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality Circulation 121 2010 214 220
17. J.A. Yang, T.S. Kato, and B.P. Shulman et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system J Heart Lung Transplant 31 2012 601 610
18. H. Thiele, U. Zeymer, and F.J. Neumann et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock N Engl J Med 367 2012 1287 1296
19. C.M. O'Connor, and J.G. Rogers Evidence for overturning the guidelines in cardiogenic shock N Engl J Med 367 2012 1349 1350
20. J.D. Estep, A.M. Cordero-Reyes, and A. Bhimaraj et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplant JCHF 1 2013 382 388
21. T.S. Kato, A. Chokshi, and P. Singh et al. Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure J Heart Lung Transplant 31 2012 37 45
22. G. Erkilet, C. Ozpeker, and D. Bothig et al. The biomarker plasma galectin-3 in advanced heart failure and survival with mechanical circulatory support devices J Heart Lung Transplant 32 2013 221 230
23. S.G. Drakos, O. Wever-Pinzon, and C.H. Selzman et al. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery J Am Coll Cardiol 61 2013 1985 1994
24. D.J. Goldstein, S. Maybaum, and T.E. MacGillivray et al. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support J Card Fail 18 2012 392 395
25. T. Hasin, Y. Marmor, and W. Kremers et al. Readmissions after implantation of axial flow left ventricular assist device J Am Coll Cardiol 61 2013 153 163
26. S.J. Forest, R. Bello, and P. Friedmann et al. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital Ann Thorac Surg 95 2013 1276 1281
27. N.G. Smedira, K.J. Hoercher, and B. Lima et al. Unplanned hospital readmissions after HeartMate II implantationfrequency, risk factors, and impact on resource use and survival JCHF 1 2013 31 39
28. J.A. Morgan, G. Paone, and H.W. Nemeh et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device J Heart Lung Transplant 31 2012 715 718
29. O. Wever-Pinzon, C.H. Selzman, and S.G. Drakos et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II Circ Heart Fail 6 2013 517 526
30. R.C. Starling, N. Moazami, and S.C. Silvestry et al. Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
31. P. Shah, V.M. Mehta, and J.A. Cowger et al. Lactate dehydrogenase is superior to serum free hemoglobin as a marker of pump thrombosis in left ventricular assist devices J Heart Lung Transplant 32 2013 S37
32. J.A. Cowger, M.A. Romano, and P. Shah et al. Hemolysis: A harbinger of adverse outcome after left ventricular assist device implant J Heart Lung Transplant 33 2014 35 43
33. P. Shah, V.M. Mehta, J.A. Cowger, K.D. Aaronson, and F.D. Pagani Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support J Heart Lung Transplant 33 2014 102 104
34. A.K. Ravichandran, J. Parker, and E. Novak et al. Hemolysis in left ventricular assist device: A retrospective analysis of outcomes J Heart Lung Transplant 33 2014 44 50
35. J.M. Stulak, D. Lee, and J.W. Haft et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device J Heart Lung Transplant 33 2014 60 64
36. N. Moazami, C.A. Milano, and R. John et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality Ann Thorac Surg 95 2013 500 505
37. S.G. Moreno, N. Novielli, and N.J. Cooper Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation J Heart Lung Transplant 31 2012 450 458
38. J.G. Rogers, R.R. Bostic, K.B. Tong, R. Adamson, M. Russo, and M.S. Slaughter Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy Circ Heart Fail 5 2012 10 16
39. M.S. Slaughter, and J.G. Rogers Editorial Commentary: Determining the cost-effectiveness of mechanical circulatory support J Heart Lung Transplant 31 2012 448 449
40. A. Chokshi, K. Drosatos, and F.H. Cheema et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure Circulation 125 2012 2844 2853
41. K. Rajagopal, M.A. Daneshmand, and C.B. Patel et al. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation J Thorac Cardiovasc Surg 145 2013 1373 1379
42. G. D'Ancona, M. Pasic, and S. Buz et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device Ann Thorac Surg 93 2012 e89 e91
43. K.S. Parikh, A.K. Mehrotra, and M.J. Russo et al. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics JACC: Cardiovasc Interv 6 2013 84 89
44. V. Piacentino 3rd, A.M. Ganapathi, and M. Stafford-Smith et al. Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device J Thorac Cardiovasc Surg 144 2012 1217 1221
45. A.M. Segura, I. Gregoric, R. Radovancevic, Z.T. Demirozu, L.M. Buja, and O.H. Frazier Morphologic changes in the aortic wall media after support with a continuous-flow left ventricular assist device J Heart Lung Transplant 32 2013 1096 1100
46. H. Raasch, B.C. Jensen, and P.P. Chang et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation Am Heart J 164 2012 373 378
47. A.R. Garan, M. Yuzefpolskaya, and P.C. Colombo et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices. Need for primary prevention? J Am Coll Cardiol 61 2013 2542 2550
48. S. Nakahara, C. Chien, and J. Gelow et al. Ventricular arrhythmias after left ventricular assist device Circ Arrhythm Electrophysiol 6 2013 648 654
49. C.S. Almond, D.L. Morales, and E.H. Blackstone et al. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children Circulation 127 2013 1702 1711
50. P. Eghtesady, C.S. Almond, and C. Tjossem et al. Post-transplant outcomes of children bridged to transplant with the Berlin Heart EXCOR Pediatric ventricular assist device Circulation 128 2013 S24 S31
51. J. Cassidy, T. Dominguez, and S. Haynes et al. A longer waiting game: bridging children to heart transplant with the Berlin Heart EXCOR device - the United Kingdom experience J Heart Lung Transplant 32 2013 1101 1106
52. A.G. Cabrera, K.S. Sundareswaran, and A.X. Samayoa et al. Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States J Heart Lung Transplant 32 2013 1107 1113
53. J.W. Rossano, R.K. Woods, and S. Berger et al. Mechanical support as failure intervention in patients with cavopulmonary shunts (MFICS): rationale and aims of a new registry of mechanical circulatory support in single ventricle patients Congenit Heart Dis 8 2013 182 186
54. J.G. Copeland, H. Copeland, and M. Gustafson et al. Experience with more than 100 total artificial heart implants J Thorac Cardiovasc Surg 143 2012 727 734
55. M.A. Quader, D. Tang, G. Katlaps, K.B. Shah, and V. Kasirajan Total artificial heart for patients with allograft failure J Thorac Cardiovasc Surg 145 2013 e21 e23
56. M. Strueber, J.D. Schmitto, I. Kutschka, and A. Haverich Placement of 2 implantable centrifugal pumps to serve as a total artificial heart after cardiectomy J Thorac Cardiovasc Surg 143 2012 507 509
57. O.H. Frazier, and W.E. Cohn Continuous-flow total heart replacement device implanted in a 55-year-old man with end-stage heart failure and severe amyloidosis Tex Heart Inst J 39 2012 542 546
58. M.A. Acker, F.D. Pagani, and W.G. Stough et al. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States J Heart Lung Transplant 31 2012 1241 1252